Reuters logo
BRIEF-Neothetics says ‍LIPO-202 did not demonstrate improvement on any efficacy measurements
June 26, 2017 / 12:25 PM / in 6 months

BRIEF-Neothetics says ‍LIPO-202 did not demonstrate improvement on any efficacy measurements

June 26 (Reuters) - Neothetics Inc:

* Neothetics announces top-line results for phase 2 proof-of-concept study of LIPO-202 for the reduction of submental subcutaneous fat

* Says ‍LIPO-202 did not demonstrate improvement on any efficacy measurements or separation from placebo​

* Says ‍LIPO-202 continued to show a benign safety profile​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below